17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I study.
Shadad
Firas N
FN
Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, PA 15232, USA.
Ramanathan
Ramesh K
RK
D000328:Adult; D016227:Benzoquinones / Q000633:toxicity*; D001853:Bone Marrow / Q000473:pathology; D006801:Humans; D047029:Lactams, Macrocyclic / Q000633:toxicity*; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy*; D009367:Neoplasm Staging; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D018579:Patient Selection
D016227:Benzoquinones; D047029:Lactams, Macrocyclic; C448659:17-(dimethylaminoethylamino)-17-demethoxygeldanamycin